These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 14746372)
1. Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Murillo-Rodriguez E; Blanco-Centurion C; Sanchez C; Piomelli D; Shiromani PJ Sleep; 2003 Dec; 26(8):943-7. PubMed ID: 14746372 [TBL] [Abstract][Full Text] [Related]
2. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. Justinová Z; Ferré S; Redhi GH; Mascia P; Stroik J; Quarta D; Yasar S; Müller CE; Franco R; Goldberg SR Addict Biol; 2011 Jul; 16(3):405-15. PubMed ID: 21054689 [TBL] [Abstract][Full Text] [Related]
3. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis. Murillo-Rodríguez E; Machado S; Rocha NB; Budde H; Yuan TF; Arias-Carrión O Neuroscience; 2016 Dec; 339():433-449. PubMed ID: 27746343 [TBL] [Abstract][Full Text] [Related]
4. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Underdown NJ; Hiley CR; Ford WR Br J Pharmacol; 2005 Nov; 146(6):809-16. PubMed ID: 16158067 [TBL] [Abstract][Full Text] [Related]
5. Intrahippocampal administration of anandamide increases REM sleep. Rueda-Orozco PE; Soria-Gómez E; Montes-Rodríguez CJ; Pérez-Morales M; Prospéro-García O Neurosci Lett; 2010 Apr; 473(2):158-62. PubMed ID: 20188142 [TBL] [Abstract][Full Text] [Related]
6. The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. Murillo-Rodríguez E; Millán-Aldaco D; Di Marzo V; Drucker-Colín R Neuroscience; 2008 Nov; 157(1):1-11. PubMed ID: 18822353 [TBL] [Abstract][Full Text] [Related]
7. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800 [TBL] [Abstract][Full Text] [Related]
8. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Wiley JL; Razdan RK; Martin BR Life Sci; 2006 Dec; 80(1):24-35. PubMed ID: 16978656 [TBL] [Abstract][Full Text] [Related]
10. A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. Solbrig MV; Adrian R; Baratta J; Piomelli D; Giuffrida A Exp Neurol; 2005 Aug; 194(2):355-62. PubMed ID: 16022863 [TBL] [Abstract][Full Text] [Related]
11. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884 [TBL] [Abstract][Full Text] [Related]
12. Regulation of subthalamic neuron activity by endocannabinoids. Morera-Herreras T; Ruiz-Ortega JA; Taupignon A; Baufreton J; Manuel I; Rodriguez-Puertas R; Ugedo L Synapse; 2010 Sep; 64(9):682-98. PubMed ID: 20336631 [TBL] [Abstract][Full Text] [Related]
13. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. Haller VL; Stevens DL; Welch SP Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181 [TBL] [Abstract][Full Text] [Related]
14. Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels. Reis GM; Ramos MA; Pacheco Dda F; Klein A; Perez AC; Duarte ID Life Sci; 2011 Apr; 88(15-16):653-7. PubMed ID: 21277864 [TBL] [Abstract][Full Text] [Related]
15. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Jamshidi N; Taylor DA Br J Pharmacol; 2001 Nov; 134(6):1151-4. PubMed ID: 11704633 [TBL] [Abstract][Full Text] [Related]
16. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. Murillo-Rodríguez E; Millán-Aldaco D; Palomero-Rivero M; Mechoulam R; Drucker-Colín R FEBS Lett; 2006 Aug; 580(18):4337-45. PubMed ID: 16844117 [TBL] [Abstract][Full Text] [Related]
17. Psychopharmacology of the endocannabinoids: far beyond anandamide. Pamplona FA; Takahashi RN J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605 [TBL] [Abstract][Full Text] [Related]
18. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum. Ghasemi M; Sadeghipour H; Mani AR; Tavakoli S; Hajrasouliha AR; Ebrahimi F; Dehpour AR Eur J Pharmacol; 2006 Aug; 544(1-3):138-45. PubMed ID: 16824514 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Herradón E; Martín MI; López-Miranda V Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831 [TBL] [Abstract][Full Text] [Related]
20. Effects of intrathecal anandamide on somatosensory evoked responses in rats. Bir LS; Ercan S Exp Neurol; 2006 Feb; 197(2):386-90. PubMed ID: 16289169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]